“Digoxin toxicity”的搜索结果，显示 341-350 项，共有 11960 项

1. 外科 - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to characterize the safety, dose limiting toxicities (DLTs), maximum tolerated dose (MTD), maximum administered ...

2. 外科 - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to characterize the safety, dose limiting toxicities (DLTs), maximum tolerated dose (MTD), maximum administered ...

3. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...

4. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...

5. 外科 - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to characterize the safety, dose limiting toxicities (DLTs), maximum tolerated dose (MTD), maximum administered ...

6. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...

7. 神经科- 临床试验- 妙佑医疗国际

   ... toxicities [DLTs] and the total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering ...

8. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Effective treatments for recurrent gynecological cancer are lacking, and there is a need for novel therapeutic options. One of the barriers to improving ...

10. 血液科- 临床试验- 妙佑医疗国际

    The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...